Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Buyout chatter pushed shares of Shire plc (FTSE:SHP) up nearly 2% in London yesterday and added 1.4% on Wall Street. Rumors of a £16 billion (~$25.1 billion) or £30-per-share (~$47.10) cash offer from Bayer AG (PINK:BAYRY) and Pfizer (NYSE:PFE) spurred the high-volume trading, driven by the additive value of Shire’s May 2011 buyout of Advanced BioHealing.
Health care giant Johnson & Johnson (NYSE:JNJ) submitted concessions to the European Commission reviewing the company’s $21.3 billion buyout of Synthes Inc. in hopes of easing regulator concerns.
The medical device industry will have its voice heard on Capitol Hill next week, as delegations for med-tech and other life science sectors from 18 states converge on the nation’s capitol to conduct coordinated visits to their local representatives in Congress.